Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Warminster, PA
SEC filing record 1 source field available
Fiscal year end
31 December
Arbutus Biopharma Corp has filed 1,026 SEC EDGAR filings since 30 Sep 2008

SEC filing history

Showing 826-850 of 1,000 matching filings.

Per page
25
Current page
34
8-K File 001-34949

FORM 8-K FILING DOCUMENT

Filing date
14 May 2014
Reporting date
14 May 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-34949

8-K filing

Filing date
12 May 2014
Reporting date
08 May 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-34949

FORM 8-K FILING DOCUMENT

Filing date
08 May 2014
Reporting date
07 May 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-34949

FORM 8-K FILING DOCUMENT

Filing date
29 Apr 2014
Reporting date
28 Apr 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-34949

FORM 8-K

Filing date
08 Apr 2014
Reporting date
08 Apr 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-34949

FORM 8-K FILING DOCUMENT

Filing date
01 Apr 2014
Reporting date
01 Apr 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-34949

FORM 6-K

Filing date
21 Mar 2014
Reporting date
20 Mar 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-34949

FORM 6-K FILING DOCUMENT

Filing date
18 Mar 2014
Reporting date
18 Mar 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
SUPPL File 333-194068

SUPPL

Filing date
13 Mar 2014
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-34949

FORM 6-K FILING DOCUMENT

Filing date
13 Mar 2014
Reporting date
13 Mar 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
SUPPL File 333-194068

SUPPL

Filing date
10 Mar 2014
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-34949

FORM 6-K FILING DOCUMENT

Filing date
10 Mar 2014
Reporting date
10 Mar 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-34949

FORM 6-K FILING DOCUMENT

Filing date
06 Mar 2014
Reporting date
06 Mar 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-34949

FORM 6-K FILING DOCUMENT

Filing date
05 Mar 2014
Reporting date
05 Mar 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
EFFECT File 333-194068

EFFECT filing

Filing date
28 Feb 2014
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
F-10/A File 333-194068

F-10/A

Filing date
28 Feb 2014
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-34949

FORM 6-K FILING DOCUMENT

Filing date
25 Feb 2014
Reporting date
25 Feb 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
F-X File 333-194068

FORM F-X

Filing date
21 Feb 2014
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-34949

FORM 6-K FILING DOCUMENT

Filing date
21 Feb 2014
Reporting date
21 Feb 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
F-10 File 333-194068

FORM F-10

Filing date
21 Feb 2014
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-85963

SC 13G/A filing

Filing date
18 Feb 2014
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-85963

TEKMIRA PHARMACEUTICALS 13G/A

Filing date
13 Feb 2014
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .